May 2003
Volume 44, Issue 13
ARVO Annual Meeting Abstract  |   May 2003
Fumaric Acid Ester Stimulates T Helper 2 Cytokine Responses and Improves Experimental HSV-1 Keratitis
Author Affiliations & Notes
  • A. Heiligenhaus
    Ophthalmology, Ophtha-Lab, Muenster, Germany
  • H. Li
    Ophthalmology, Ophtha-Lab, Muenster, Germany
  • S. Wasmuth
    Ophthalmology, University, Essen, Germany
  • D. Bauer
    Ophthalmology, University, Essen, Germany
  • Footnotes
    Commercial Relationships  A. Heiligenhaus, Fumapharm R; H. Li, None; S. Wasmuth, None; D. Bauer, None.
  • Footnotes
    Support  DFG grant He 1877/12-1
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 4752. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Heiligenhaus, H. Li, S. Wasmuth, D. Bauer; Fumaric Acid Ester Stimulates T Helper 2 Cytokine Responses and Improves Experimental HSV-1 Keratitis . Invest. Ophthalmol. Vis. Sci. 2003;44(13):4752.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Fumaric acid esters have proved to stimulate T helper 2 cytokine responses while the T helper 1 cytokine response is unaffected. This study was performed to investigate their influence on the course of herpes stromal keratitis (HSK). Methods: The corneas of BALB/c mice were inoculated with 105 PFU of HSV-1 (KOS strain). Groups of mice were treated systemically with vehicle (group 1), or with dimethylfumarate (DMF): for 28 days pre-infection (group 2), for 14 days post-infection (group 3), or pre- and post-infection (group 4). The course of HSV-1 keratitis was studied clinically and histologically. The eyes were tested for virus replication by standard plaque assay. The DTH response was determined, and the HSV-1 specific proliferative response of cells from regional lymph-nodes and spleens was measured. Results: On day 14 after HSV infection, 72% of the mice in group 1 (n=14) had severe stromal keratitis. The development of stromal keratitis was reduced by DMF treatment in group 2 (35,2%, n=17), in group 3 (35%, n=20) and in group 4 (22%, n=19). Virus clearance and DTH were not influenced by DMF injections. The DMF treated mice had slightly decreased HSV-1 specific proliferative responses. Conclusions: The data suggest that the course of herpes stromal keratitis can be improved with fumaric acid esters that augment T helper 2 cytokine production.

Keywords: herpes simplex virus • immunomodulation/immunoregulation • keratitis 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.